New CRISPR approach may open path to hepatitis E treatment by blocking viral RNA
Researchers at Ruhr University Bochum have developed a novel antiviral concept: using the CRISPR/Cas13 system, they were able to specifically suppress the replication of hepatitis E virus in human cells. Hepatitis E is a common cause of acute liver inflammation worldwide, yet effective specific treatments are still lacking. The team has now demonstrated that the…
